Home > Media & Technology > Next Generation Technologies > AI and Machine Learning > Vertical AI Market

Vertical AI Market Share

Report ID: GMI12504
Published Date: Dec 2024
Report Format: PDF

Download Free Sample

Vertical AI Market Share

Recursion Pharmaceuticals and Path AI hold a market share of over 5% in the vertical AI industry. Recursion Pharmaceuticals is strengthening its capabilities through strategic mergers, such as its recent merger with Exscientia. This partnership combines Recursion's expertise in large-scale biological research with Exscientia's advanced chemistry tools, creating a comprehensive AI-driven platform for small molecule discovery. Additionally, Recursion is partnering with major pharmaceutical companies such as Roche, Genentech, and Bayer, focusing on neuroscience, gastrointestinal oncology, and difficult-to-treat oncology targets.

PathAI is improving diagnostic accuracy in pathology through machine learning. By enhancing AI algorithms for disease detection and treatment response, PathAI is transforming traditional pathology workflows into advanced, AI-driven systems. The company has collaborated with global healthcare leaders including Labcorp, Bristol-Myers Squibb, and Roche. These alliances aim to integrate AI into diagnostics and treatment decision-making, showcasing PathAI’s strategy to embed its solutions across various healthcare segments.

Vertical AI Market Companies

Major players operating in the vertical AI industry include:

Atomwise
BenevolentAI
Blue River Technology
Databricks
Farmers Edge
Harvey AI
Insilico Medicine
Nauto
Path AI
Recursion Pharmaceuticals

Authors: Preeti Wadhwani, Aishwarya Ambekar

Frequently Asked Questions (FAQ) :

The market size of vertical AI reached USD 10.2 billion in 2024 and is set to grow at a 21.6% CAGR from 2025 to 2034, driven by the increasing demand for industry-specific AI solutions.

The machine learning segment captured 36% of the market share in 2024, benefiting sectors like retail, finance, and insurance by enabling businesses to predict future trends through historical data analysis.

The North America market accounted for 40% of the revenue share in 2024, led by strong tech infrastructure and significant investment opportunities in AI innovation.

The key players in the industry include Atomwise, BenevolentAI, Blue River Technology, Databricks, Farmers Edge, Harvey AI, Insilico Medicine, Nauto, Path AI, and Recursion Pharmaceuticals.